ARWR
Arrowhead Pharmaceuticals, Inc.
$43.11+0.12 (+0.28%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Dec 16, 1993 – Nov 18, 2026, Dividends reinvested
- Final balance
- $147
- CAGR
- −12.02%
- Max drawdown
- −99.96%
Trailing returns (%)
ARWR's average annual return was 25.58% over the last 10 years and −0.49% over the last 20 years, through Nov 18, 2026. $10,000 in ARWR on Nov 18, 2016 grew to $97,534 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −22.88%
- 3M
- −50.96%
- 6M
- −41.70%
- YTD
- −35.07%
- 1Y
- +6.52%
Per year
- 3Y
- +15.39%
- 5Y
- −9.43%
- 10Y
- +25.58%
- 15Y
- +14.67%
- 20Y
- −0.49%
- 25Y
- +4.91%
- 30Y
- −5.04%
- Since 1993
- −12.02%
Annual returns
1993 from Dec 16 · 2026 through Nov 18
ARWR returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −35.07% |
| 2025 | +253.14% |
| 2024 | −38.56% |
| 2023 | −24.56% |
| 2022 | −38.82% |
| 2021 | −13.59% |
| 2020 | +20.97% |
| 2019 | +410.71% |
| 2018 | +237.50% |
| 2017 | +137.42% |
Metrics
Since 1993| Volatility | 231.75% |
|---|---|
| Sharpe ratio | 0.71 |
| Sortino ratio | 1.74 |
| Calmar ratio | −0.12 |
| Longest drawdown | 32.9 years |
Worst drawdowns
Since 1993| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −99.9% | Dec 1993 | Dec 2016 | Not yet | 32.9 years so far |